国际麻醉学与复苏杂志   2017, Issue (6): 8-8
    
美托咪定联合舒芬太尼用于老年患者全髋置换术后自控静脉镇痛
赵晓英1()
1.山西医科大学第二医院麻醉科
Clinical study of administration of dexmedetomidine combined Sufentanil for postoperative analgesia in elderly patients with total hip replacement
 全文:
摘要:

目的 探讨右美托咪定联合舒芬太尼用于老年患者全髋置换术后自控静脉镇痛(PCIA)的临床安全性和有效性。方法 选择择期行全髋关节置换手术的患者90例,年龄65~89岁,ASAⅠ~ Ⅲ分级,采用随机数字表法随机分为3组,每组30例。舒芬太尼组(S组)、右美托咪定1组(D1组)和右美托咪定2组(D2组)。S组:舒芬太尼0.04 ug·kg-1·h-1 +托烷司琼5 mg + 生理盐水,总量120 ml进行PCIA;D1组舒芬太尼0.04 ug·kg-1·h-1 +托烷司琼5 mg+右美托咪定0.02 ug·kg-1·h-1 + 生理盐水,总量120 ml进行PCIA;D2组舒芬太尼0.04 ug·kg-1·h-1 +托烷司琼5 mg+右美托咪定0.05 ug·kg-1·h-1 + 生理盐水,总量120 ml进行PCIA。所有患者麻醉方式均采用蛛网膜下腔阻滞,穿刺间隙L3-4。在手术结束前10 min,均静脉注射5 ug舒芬太尼,然后连接静脉镇痛泵,背景输注速度2 ml·h-1,锁定时间15 min,一次按压2 ml。记录手术和麻醉时间,术中出血量,术后镇痛不良反应(皮肤瘙痒、恶心呕吐)的发生率,镇痛总体舒适度评分(BCS评分),术后4、8、12、24、48 h的VAS疼痛评分和Ramsay镇静评分,记录PCA键的有效按压次数,计算镇痛48h后各组单位体重下舒芬太尼的消耗量。结果 术后8~48 h,S组Ramsay评分明显低于D1组和D2组(P < 0.05);D1组和D2组比较,差异无统计学意义。术后12、24 h,D1组VAS评分时点明显低于S组(P<0.05),术后8~48 h D2组明显低于S组(P < 0.01)。镇痛48 h后,D1组BCS评分高于S组(P < 0.01),D2组明显高于S组与D1组(P < 0.05, P < 0.01);S组舒芬太尼消耗量明显大于D1组和D2组(P<0.05, P < 0.01),D1组和D2组差异无统计学意义。结论 右美托咪定0.05 ug·kg-1·h-1联合舒芬太尼0.04 ug·kg-1·h-1自控静脉镇痛用于老年患者髋关节置换术后有较好的术后镇痛效果,且降低了舒芬太尼的消耗量,临床应用安全、可行、有效。

关键词: 右美托咪定;老年患者;舒芬太尼;术后镇痛;髋关节置换
Abstract:

Objective To explore the viable protocol of dexmedetomidine combined sufentanil intravenous infusion for postoperative analgesia in elderly patients with total hip replacement. Methods The ninety elderly patients(age:65~89years),ASAⅠ~ Ⅲ, with total hip replacement were randomly divided into 3 groups:①group of sufentanil (S) (n=30): sufentanil 0.04 ug·kg-1·h-1 and tropisetron 5 mg were dissolved in 120 ml normal saline for PCIA. ② group of dexmedetomidine 1(D1) (n=30): sufentanil 0.04 ug·kg-1·h-1, tropisetron 5 mg and dexmedetomidine 0.02 ug·kg-1·h-1 were dissolved in 120 ml normal saline for PCIA. ③group of dexmedetomidine 2 (D2) (n=30): sufentanil 0.04 ug·kg-1·h-1,tropisetron 5 mg and dexmedetomidine 0.05 ug·kg-1·h-1 were dissolved in 120 ml normal saline for PCIA . All patients’ anesthesia were performed by spinal block in L3-4. Sufentanil with 5 ug intravenous injection was administrated in all of groups 10 min before the end of operation. The patient controlled analgesia (PCA) program of all postoperative analgesia pumps was set with background infusion of 2 ml·h-1, a lockout of 15 min and a delivery of a bolus dose of 2 ml. The time of operation and anesthesia, amount of bleeding during operation, the incidence of adverse reactions ( pruritus, nausea and emesis) for postoperative analgesia, the BCS scores, and the consumptions of sufentanil for 48 h analgesia were recorded. In addition, VAS scores and Ramsay scores were also recorded at postoperative 4, 8, 12, 24, 48 h. Results At the 8~48 h after operation, the Ramsay score of group S was lower compared with group D1 and group D2(P<0.05, P < 0.01); group D1 was no significant difference compared to group D2 . In assessment of the VAS score,group D1 was lower at the 12 h and 24 h after operation compared with group S(P < 0.05),but group D2 was lower at 8~48 h compared with group S(P<0.05). In assessment of BCS score for 48 h analgesia, group D1 was higher than group S(P < 0.01), and group D2 was significantly higher than all of group S and groupD1(P<0.01, P <0.05). In Assessment of consumption of sufentanil for 48 h analgesia, the consumption of group S was apparently bigger compared with group D1 and group D2(P < 0.05,P < 0.01). When group D2 compared with group D1,there was no significant difference. Conclusion The protocol of dexmedetomidine 0.05 ug·kg-1·h-1 combined sufentanil 0.04 ug·kg-1·h-1 intravenous infusion for postoperative analgesia in elderly patients with total hip replacement has better analgesic effect , greater patient satisfaction, reduces the total consumption of sufentanil and is safety and feasibility for clinical application.

Key words: Dexmedetomidine; Elderly patients; Sufentanil; Postoperative analgesia; Hip replacement